Cite
APA Citation
Kawada, J., Sugimoto, N., Hirokazu, T., Ueda, S., Murakami, K., Nishikawa, K., Kurokawa, Y., Fujitani, K., Kawakami, H., Sakai, D., Shimokawa, T., & Satoh, T. (n.d.). p-180A phase 2 study of capecitabine plus oxaliplatin therapy (XELOX) for patients with inoperable/advanced gastric cancer who were resistant/intolerable to fluoropyrimidine, CDDP, taxane, and CPT-11 (OGSG1403). Annals of oncology, 30, . http://access.bl.uk/ark:/81055/vdc_100094625524.0x000024